Histologic Patterns of Melanocytic Nevi: A Proposal for a New Classification

May 2007 | Volume 6 | Issue 5 | Original Article | 487 | Copyright © May 2007


Robert M. Hurwitz MD, Larry J. Buckel MD, Thomas J. Eads MD

Dermatopathology Laboratory, PC, Inc, Indianapolis, IN

table 1
    plained by any preexisting disease, concomitant drug use, or other chemical substance. Information about the patient discontinuing use of the drug is not complete or is not available.
  1. Unlikely: The adverse reaction occurred during a time period that does not correspond to the drug usage, and cannot be explained by any preexisting disease, concomitant drug use, or other chemical substance.
  2. Unclassified: More data are essential for a proper assessment or those additional data are under examination.
  3. Unclassifiable: The information is insufficient or contradictory, which makes it impossible to judge the relationship between the health product and the adverse event. Data cannot be supplemented or verified.
Individuals 18 years and older with a history of cutaneous adverse drug reactions from PPIs at Siriraj Hospital from January 2005 through May 2010 were included in a study group. After identifying each study case, the next 15 patients with consecutive hospital numbers were sampled, and one who had received PPIs during the study period without adverse reaction was chosen for the control group. Inpatient and outpatient data of the case and control subjects were reviewed retrospectively. The prescription data of each PPI were obtained from the database at the Information Technology Center at Siriraj Hospital.

Statistical Analysis

Descriptive statistics, eg, mean, median, minimum, maximum, and percentages, were used to describe demographic data, cutaneous adverse drug reactions, and clinical characteristics.
table 2